PRMT1 and familial pancreatic carcinoma: Combination of inhibitors of PRMT1 and PRMT5 has a synergistic cancer cell growth inhibition in pancreatic cancer and DLBCL cell lines and in pancreatic adenocarcinoma xenografts mouse models 48.